PYC Therapeutics (PYC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period PYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA TherapiesApril 16, 2025 | tipranks.comPYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease TrialApril 9, 2025 | tipranks.comPYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter DelaysApril 8, 2025 | tipranks.comPYC Therapeutics Updates Investors on Business ProgressMarch 27, 2025 | tipranks.comBuy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic MedicineMarch 25, 2025 | tipranks.comPYC Therapeutics Launches Retail Entitlement Offer to Fund RNA Therapy DevelopmentFebruary 23, 2025 | tipranks.comPYC Therapeutics Launches $146 Million Entitlement OfferFebruary 23, 2025 | tipranks.comPYC Therapeutics to Raise $146 Million for Drug Pipeline AdvancementFebruary 16, 2025 | tipranks.comPYC Therapeutics Launches Equity Raising to Bolster Financial PositionFebruary 16, 2025 | tipranks.comPYC Therapeutics to Issue 116.6 Million Securities in Accelerated OfferFebruary 16, 2025 | tipranks.comPYC Therapeutics Launches A$145.8 Million Entitlement OfferFebruary 16, 2025 | tipranks.comPYC Therapeutics Gains Approval for PKD Drug Human TrialsFebruary 9, 2025 | tipranks.comPYC Therapeutics Secures FDA Rare Disease Designation for VP-001January 19, 2025 | tipranks.comPYC Therapeutics Updates on Kidney Disease ResearchNovember 27, 2024 | tipranks.comPYC Therapeutics Expands Employee Incentive OptionsNovember 27, 2024 | tipranks.comPYC Therapeutics Advances Kidney Disease Drug TrialsNovember 26, 2024 | tipranks.comUS FDA DESIGNATES PYC'S LEAD AS A FAST TRACK DEVELOPMENT PROGRAMAugust 11, 2023 | finance.yahoo.comPYC.AX - PYC Therapeutics LimitedJuly 24, 2023 | au.finance.yahoo.comASX Health Stocks: Successful toxicology tests pave the way for PYC’s Phase 2 clinical trialJuly 17, 2023 | msn.comNon-Executive Chair of the Board of PYC Therapeutics Alan Tribe Buys 26% More SharesJuly 15, 2023 | finance.yahoo.comASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTATMarch 5, 2023 | msn.comOwning 50% in PYC Therapeutics Limited (ASX:PYC) means that insiders are heavily invested in the company's futureJanuary 13, 2023 | finance.yahoo.comPYC Therapeutics Limited (ASX:PYC) insider upped their holding by 0.2% earlier this yearDecember 23, 2022 | nz.finance.yahoo.comWill PYC Therapeutics (ASX:PYC) Spend Its Cash Wisely?November 22, 2022 | finance.yahoo.comPYC Therapeutics Limited (PYC.AX)September 14, 2022 | finance.yahoo.comPYC Therapeutics LtdAugust 16, 2022 | reuters.comAHF Sounds ‘Monkeypox: LA County Alert’ in Latest LA Times AdAugust 8, 2022 | nz.finance.yahoo.comBond Traders on Collision Course With Fed Over Longer-Term ViewAugust 8, 2022 | nz.finance.yahoo.comWe're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash WiselyJune 7, 2022 | finance.yahoo.comThose who invested in PYC Therapeutics (ASX:PYC) three years ago are up 256%May 9, 2022 | finance.yahoo.comHow to Increase the Competitive Advantage of Your Small to Midsize BusinessMarch 2, 2022 | news.yahoo.comKillearn Golf & Country Club on verge of new ownership, 'massive revitalization' on horizonMarch 1, 2022 | news.yahoo.comWhat Is The Ownership Structure Like For PYC Therapeutics Limited (ASX:PYC)?February 27, 2022 | finance.yahoo.comShield Thera Share ChatFebruary 23, 2022 | lse.co.ukBritain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized PatientsJanuary 24, 2022 | msn.comPYC Therapeutics Limited (ASX:PYC) insider upped their holding by 0.06% earlier this yearDecember 30, 2021 | finance.yahoo.comCompanies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In GrowthNovember 15, 2021 | finance.yahoo.com Get PYC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Email Address PYC Media Mentions By Week PYC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PYC News Sentiment▼0.000.86▲Average Medical News Sentiment PYC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PYC Articles This Week▼00▲PYC Articles Average Week Get PYC Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONT News Today GNS News Today BIO News Today ZBIO News Today PRTC News Today OXB News Today FARN News Today CYBN News Today 4BB News Today FRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:PYC) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PYC Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share PYC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
